PTPRC and cancer: To verify the types of fibroblasts and myofibroblasts, we employed anti-human CD31, CDX2, Cytokeratin 20, and CD45 antibodies to stain endothelial cells of blood vessels, inflammatory cells and epithelial cells or cancer cells in the tissues of samples.